China’s Kintor says interim analysis of COVID treatment trial misses statistical criteria - News Summed Up

China’s Kintor says interim analysis of COVID treatment trial misses statistical criteria


Just approved by the Food and Drug Administration, Vuity's new product has been found to take effect in as little as 15 minutes. It’s one of the more irritating side effects of aging: blurred close-up...


Source: National Post December 28, 2021 02:21 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */